【北京，中国 – BusinessWire】全球医疗技术领域的创新力量Zephyr AI近日宣布，该公司在A轮融资中成功筹集了1.11亿美元。这标志着这家专注于精准医疗AI算法的初创公司在其发展道路上迈出了重要一步。本轮融资由知名投资机构Revolution Growth领投，同时获得了制药巨头礼来公司、社会企业家Jeff Skoll以及EPIQ Capital Group等重量级投资者的大力支持。
Zephyr AI致力于研发高效且可解释的人工智能解决方案，以推动医疗行业的精准医疗进程。通过其创新技术，公司旨在解决医疗领域中数据解读和个性化治疗方案制定的挑战，从而提升医疗服务质量，改善患者预后。
此次融资的顺利完成，将为Zephyr AI提供必要的资金，加速其AI算法的研发和商业化进程，同时可能加深与礼来等医药巨头的合作，共同探索AI在药物研发和临床实践中的应用。Zephyr AI的创始人兼首席执行官表示，他们将利用这笔资金扩大团队规模，加强技术平台，并扩大在全球范围内的市场影响力。
随着全球医疗行业对AI技术的日益关注，Zephyr AI的这一轮融资不仅体现了投资者对其技术实力和市场前景的信心，也预示着AI在精准医疗领域将发挥更大的作用，有望重塑医疗保健的未来。
英语如下：
**News Title:** “Zephyr AI Raises $110M in Series A Funding, Pioneering a New Chapter in Precision Medicine AI”
**Keywords:** Zephyr AI, Precision Medicine, Series A Funding
**News Content:** **Beijing, China – BusinessWire** – Zephyr AI, a global innovator in the medical technology sector, recently announced that it has successfully raised $111 million in its Series A funding round. This milestone signifies a significant step forward for the startup, which specializes in AI algorithms for precision medicine.
The funding round was led by prominent investment firm Revolution Growth, with strong support from pharmaceutical giant Eli Lilly, social entrepreneur Jeff Skoll, and influential investor EPIQ Capital Group.
Dedicated to developing efficient and explainable AI solutions, Zephyr AI aims to propel the precision medicine process within the healthcare industry. By addressing challenges in data interpretation and personalized treatment planning, the company strives to enhance healthcare quality and improve patient outcomes.
The completion of this funding round will provide Zephyr AI with the resources to accelerate AI algorithm development and commercialization. It may also deepen collaborations with医药 majors like Eli Lilly, exploring AI applications in drug discovery and clinical practice. The founder and CEO of Zephyr AI stated that the funds will be utilized to expand the team, strengthen the technology platform, and augment the company’s global market presence.
As the healthcare industry worldwide increasingly embraces AI technology, Zephyr AI’s fundraising not only underscores investors’ confidence in its technological prowess and market prospects but also foreshadows a larger role for AI in precision medicine, potentially reshaping the future of healthcare.
【来源】https://www.businesswire.com/news/home/20240312475536/en/Zephyr-AI-Raises-111-Million-in-Series-A-Financing
Views: 4